68Ga-NODAGA-SNA009

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug Name68Ga-NODAGA-SNA009
Drug Alias Name68Ga-NODAGA-SNA009
ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell surface A33 antigen modulators
TargetsCell surface A33 antigen
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSmartnuclide Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesSmartnuclide Biopharma
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A